. Overview We are a medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the OCS to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide. Our innovative OCS technology replicates many aspects of the organs natural living and functioning environment outside of the human body. As such, the ...
Q2 FY2026 — expected 2026-07-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001193125-26-067032 | EDGAR | 91K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-029104 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021155 | EDGAR | — |
| 2023-02-27 | 2022-12-31 | 0000950170-23-004652 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001564590-22-008045 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012527 | EDGAR | — |
| 2020-03-17 | 2019-12-28 | 0001564590-20-011409 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-29 | 2025-09-30 | 0001193125-25-256377 | EDGAR | 28K words |
| 2025-07-30 | 2025-06-30 | 0000950170-25-100314 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-067004 | EDGAR | — |
| 2024-10-29 | 2024-09-30 | 0000950170-24-118260 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000950170-24-089316 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0000950170-24-052179 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-061218 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0000950170-23-038605 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017909 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001564590-22-036772 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001564590-22-027757 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001564590-22-018257 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-27 | 0001193125-26-079392 | EDGAR | 1K words |
| 2026-02-24 | 0001193125-26-066953 | EDGAR | — |
| 2026-02-04 | 0001193125-26-037615 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009816 | EDGAR | — |
| 2025-10-29 | 0001193125-25-256326 | EDGAR | — |
| 2025-10-06 | 0001193125-25-231900 | EDGAR | — |
| 2025-07-30 | 0000950170-25-100228 | EDGAR | — |
| 2025-05-23 | 0001193125-25-125855 | EDGAR | — |
| 2025-05-08 | 0000950170-25-066916 | EDGAR | — |
| 2025-02-27 | 0000950170-25-029071 | EDGAR | — |
124 total filings indexed. 95 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001756262 |
| Ticker | TMDX |
| Exchange | Nasdaq |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | MA |
| Website | https://www.transmedics.com |
| Listed | 2019-05-02 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report